Study Summary
This trial is studying the effects of TMS on motor cortex excitability in people who have had a stroke, and how the phase of the oscillatory rhythm (mu frequency) affects motor excitability in stroke patients.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 3 hours
3 hours
Motor evoked potentials (MEPs)
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Participants With Unilateral Stroke
1 of 2
Participants Without Unilateral Stroke
1 of 2
Experimental Treatment
72 Total Participants · 2 Treatment Groups
Primary Treatment: Transcranial magnetic stimulation (TMS) · No Placebo Group · N/A
Participants With Unilateral Stroke
Device
Experimental Group · 1 Intervention: Transcranial magnetic stimulation (TMS) · Intervention Types: DeviceParticipants Without Unilateral Stroke
Device
Experimental Group · 1 Intervention: Transcranial magnetic stimulation (TMS) · Intervention Types: DeviceTreatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial magnetic stimulation (TMS)
2013
Completed Phase 4
~510
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 3 hours
Who is running the clinical trial?
University of MinnesotaLead Sponsor
1,256 Previous Clinical Trials
1,483,850 Total Patients Enrolled
34 Trials studying Stroke
50,691 Patients Enrolled for Stroke
Alexander Opitz, PhDPrincipal InvestigatorUniversity of Minnesota Department of Biomedical Engineering
2 Previous Clinical Trials
42 Total Patients Enrolled
Eligibility Criteria
Age 18+ · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Conditions
Cancer Related
Treatments